建發國際集團(01908.HK)前三季歸屬股東權益合同銷售金額約1013.3億元 同比增加36.6%
格隆匯10月3日丨建發國際集團(01908.HK)公吿,集團截至2023年9月30日止9個月的若干未經審核營運數據。根據對集團截至2023年9月30日止9個月未經審核綜合管理賬目的初步審閲,截至2023年9月30日止9個月,集團連同其合營公司及聯營公司實現歸屬公司股東權益的累計合同銷售金額約人民幣1013.3億元,歸屬公司股東權益的累計合同銷售面積約458.8萬平方米,同比分別增加約36.6%和約18.0%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.